These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 8529801

  • 1. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies.
    Linz W, Wiemer G, Schölkens BA.
    Diabetes; 1996 Jan; 45 Suppl 1():S51-8. PubMed ID: 8529801
    [Abstract] [Full Text] [Related]

  • 2. Beneficial effects of bradykinin on myocardial energy metabolism and infarct size.
    Linz W, Wiemer G, Schölkens BA.
    Am J Cardiol; 1997 Aug 04; 80(3A):118A-123A. PubMed ID: 9293964
    [Abstract] [Full Text] [Related]

  • 3. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W, Wiemer G, Gohlke P, Unger T, Schölkens BA.
    Pharmacol Rev; 1995 Mar 04; 47(1):25-49. PubMed ID: 7784479
    [Abstract] [Full Text] [Related]

  • 4. Cardioprotective actions of bradykinin in myocardial ischemia and left ventricular hypertrophy.
    Linz W, Wiemer G, Schölkens BA.
    Braz J Med Biol Res; 1994 Aug 04; 27(8):1949-54. PubMed ID: 7749386
    [Abstract] [Full Text] [Related]

  • 5. Local inhibition of bradykinin degradation in ischemic hearts.
    Linz W, Martorana PA, Schölkens BA.
    J Cardiovasc Pharmacol; 1990 Aug 04; 15 Suppl 6():S99-109. PubMed ID: 1697370
    [Abstract] [Full Text] [Related]

  • 6. [Cardioprotective effects by ramipril after ischemia and reperfusion in animal experiment studies].
    Linz W, Wiemer G, Gohlke P, Unger T, Schölkens BA.
    Z Kardiol; 1994 Aug 04; 83 Suppl 4():53-6. PubMed ID: 7856280
    [Abstract] [Full Text] [Related]

  • 7. Possible protective effects of kinins and converting enzyme inhibitors in cardiovascular tissues.
    Nolly H, Miatello R, Damiani MT, Abate CD.
    Immunopharmacology; 1997 Jun 04; 36(2-3):185-91. PubMed ID: 9228545
    [Abstract] [Full Text] [Related]

  • 8. The cardioprotective effect of dual metallopeptidase inhibition: respective roles of endogenous kinins and natriuretic peptides.
    Dumoulin MJ, Adam A, Burnett J, Heublein D, Yamaguchi N, Lamontagne D.
    Can J Physiol Pharmacol; 2005 Feb 04; 83(2):166-73. PubMed ID: 15791290
    [Abstract] [Full Text] [Related]

  • 9. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat.
    Wollert KC, Studer R, Doerfer K, Schieffer E, Holubarsch C, Just H, Drexler H.
    Circulation; 1997 Apr 01; 95(7):1910-7. PubMed ID: 9107180
    [Abstract] [Full Text] [Related]

  • 10. Apstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin-dependent pathway.
    Wolfrum S, Richardt G, Dominiak P, Katus HA, Dendorfer A.
    Br J Pharmacol; 2001 Sep 01; 134(2):370-4. PubMed ID: 11564655
    [Abstract] [Full Text] [Related]

  • 11. ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts.
    Linz W, Wiemer G, Schölkens BA.
    J Mol Cell Cardiol; 1992 Aug 01; 24(8):909-19. PubMed ID: 1331474
    [Abstract] [Full Text] [Related]

  • 12. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
    Gryglewski RJ, Chłopicki S, Uracz W, Marcinkiewicz E.
    Med Sci Monit; 2001 Aug 01; 7(1):1-16. PubMed ID: 11208485
    [Abstract] [Full Text] [Related]

  • 13. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.
    Liu YH, Yang XP, Sharov VG, Sigmon DH, Sabbath HN, Carretero OA.
    Hypertension; 1996 Jan 01; 27(1):7-13. PubMed ID: 8591891
    [Abstract] [Full Text] [Related]

  • 14. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors.
    Linz W, Schölkens BA.
    J Cardiovasc Pharmacol; 1992 Jan 01; 20 Suppl 9():S83-90. PubMed ID: 1282635
    [Abstract] [Full Text] [Related]

  • 15. Captopril potentiates the myocardial infarct size-limiting effect of ischemic preconditioning through bradykinin B2 receptor activation.
    Miki T, Miura T, Ura N, Ogawa T, Suzuki K, Shimamoto K, Iimura O.
    J Am Coll Cardiol; 1996 Nov 15; 28(6):1616-22. PubMed ID: 8917279
    [Abstract] [Full Text] [Related]

  • 16. Pulsatile antagonism on bradykinin 2-receptor (BK2R) by icatibant triggers the most effective kinin-dependent post-conditioning on rat hearts.
    Sgarra L, Coco C, Montagnani M, Potenza MA.
    Eur Rev Med Pharmacol Sci; 2019 May 15; 23(10):4439-4447. PubMed ID: 31173320
    [Abstract] [Full Text] [Related]

  • 17. Activation of kinins on myocardial ischemia.
    Shimamoto K, Miura T, Miki T, Iimura O.
    Agents Actions Suppl; 1992 May 15; 38 ( Pt 3)():90-7. PubMed ID: 1462887
    [Abstract] [Full Text] [Related]

  • 18. A study of the mediators involved in the protection induced by exogenous kinins in the isolated rat heart.
    Lagneux C, Adam A, Lamontagne D.
    Int Immunopharmacol; 2003 Oct 15; 3(10-11):1511-8. PubMed ID: 12946448
    [Abstract] [Full Text] [Related]

  • 19. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
    Liu YH, Yang XP, Sharov VG, Nass O, Sabbah HN, Peterson E, Carretero OA.
    J Clin Invest; 1997 Apr 15; 99(8):1926-35. PubMed ID: 9109437
    [Abstract] [Full Text] [Related]

  • 20. Contribution of bradykinin to the cardiovascular effects of ramipril.
    Linz W, Wiemer G, Schölkens BA.
    J Cardiovasc Pharmacol; 1993 Apr 15; 22 Suppl 9():S1-8. PubMed ID: 7514234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.